role of molecular genetic assessment for autism in...
TRANSCRIPT
www.mghcme.org
Role of Molecular Genetic Assessment
for Autism in Clinical Setting
Young Shin Kim, MD, MS, MPH, PhD Director
STAR Center for ASD and NDDs Psychiatric Genetic Epidemiology
Associate Professor Dept. of Psychiatry, UCSF
www.mghcme.org
Disclosures
Research Grant (Spouse): Janssen
Consultant on a non-pharmaceutical project (Spouse): Janssen
Research Support (Spouse): NIH
www.mghcme.org
Purpose of Molecular Genetic Diagnoses
• Gain access to additional resources through their insurance company or school district
• Family support groups and online communities
• Decrease parental feelings of guilt
• Better anticipatory guidance
• Better genetic counseling
• Take account of specific management guidelines, if available,
• Access specific treatment considerations, if available.
www.mghcme.org
If the genetics of breast cancer were simple, the counseling might look like this
www.mghcme.org
However, other genetic and environmental risk factors also play a role
www.mghcme.org
Known genetic risk factors only account for a small proportion of total risk
www.mghcme.org
‘High risk’ genes combine with the other risk factors to give a total risk
www.mghcme.org
Without additional insight (e.g. family history) it is very hard to interpret findings
Current genetic methods cannot reliably
determine where a person lies on this curve
www.mghcme.org
Case Study 1
• JP is a 16mth-old girl presenting with speech and
walking delay
• Born at 39/40 by LCSC 2o failure to progress; APGARs
8,10,10
• Parents describe normal development in first year. No
pediatrician concerns.
• Sat up at 6mths; cruising at 9mths; first step at 13mths,
but then ‘lost interest’
• First word at 11mths, but did not progress
• “A couple of months after her first birthday it felt like the
lights went out”
www.mghcme.org
Case Study 1
• Sequencing of MECP2 reveals missense mutation. Not observed in either parent.
• Diagnosed as ‘Rett Syndrome’.
• Important characteristics: – Female
– Regression
– Progression
• MECP2 gene test has to be ordered specifically.
www.mghcme.org
Mendelian causes of ASD
• In Mendelian disorders variants are:
– Necessary (mutation required for diagnosis)
– Sufficient (no other risk factors required)
• Known Mendelian causes account for <1% of
ASD
• Rett’s should be considered in a girls presenting
with ASD
www.mghcme.org
Case Study 2
• DS is a 3yr-old boy presenting with mild speech delay
and challenging behavior
• Born at 41/40 by NVD; Normal APGARs
• Several milestones slightly delayed: sat at 8mths; first
word at 15mths; first step at 16mths
• Still not speaking in complete sentences
• Difficult to get him to concentrate on one activity
• Easily upset around other children and can be slightly
rough
• Normal growth
www.mghcme.org
Case Study 2
• PCR of FMR1 reveals excess of triplet repeats
• Diagnosed as ‘Fragile X Syndrome’.
• Important characteristics:
– Male
– Reduced IQ/ASD
– (Anticipation)
• FMR1 gene test has to be ordered specifically.
www.mghcme.org
‘Syndromic’ causes of ASD
• Variants are necessary and specific for the syndrome
• ASD is not always a feature
• Variants can be CNVs or SNVs
• Often de novo
• Usually associated with dysmorphology or characteristic symptoms
• CNVs found by microarray; single gene testing for SNVs (often requires genetics referral)
www.mghcme.org
Syndromic forms of autism
• Trisomy 21 (Down)
• X0 or XXY (Turner, Klinefelter)
• 7q11.23 (Williams)
• 22q11.2 (diGeorge/VCFS)
• 22q13 (Phelan-McDermid)
• 17p11.2 (Smith-Magenis/ Potocki-
Lupski)
• FMR1 (Fragile X)
• TSC1/2 (Tuberous Sclerosis)
• PTEN (Cowden Disease)
• CACNA1C (Timothy)
• DHCR7 (Smith-Lemli-Opitz)
• PAH (Phenylketonuria)
• SOS1, RAF1, BRAF, KRAS, MAP2K1
(Noonan)
• CHD7(CHARGE)
• UBE3A (Angelman)
• MECP2 (Rett)
• SLC6A8 (Creatine transporter)
• HPRT1 (Lesch-Nyhan)
• MBD5 (2q31 microdeletion)
• NSD1 (Sotos)
• CNTNAP2 (Cortical dysplasia-focal
epilepsy)
• TCF4 (Ptt-Hopkins)
• MED12 (Lujan-Fryns)
• ARX (ARX-related disorders)
www.mghcme.org
Some Mendelian/syndromic disorders are
potentially treatable
• PKU – dietary avoidance of phenylalanine
• Mutation in BCKDK
– inactivates amino acid breakdown
– treatment by high amino acid diet
• Usher syndrome – hearing and vision
• Cohen syndrome – vision and infection
• MECP2, AFF2 – current trials
www.mghcme.org
Case Study 3
• NP is a 6yr-old girl with a long-standing diagnosis of ASD
• Unremarkable birth history
• Presented at 2yrs of age with speech delay and mild
motor delay
• In mainstream school with support
• Head on 85th centile despite weight and height on 40th;
no overt dysmorphic features
• Microarray analysis was recently ordered
www.mghcme.org
Case Study 3
• Microarray reveals 500kb deletion in 16p11.2 region
• Diagnosed as ’16p11.2 microdeletion syndrome’
• Important characteristics:
– ‘Typical’ ASD presentation
• Microarray analysis picks up all large deletions
and duplications
– Misses inversions, translocations, and small CNVs
– ~5% diagnostic yield
www.mghcme.org
CNVs Associated with Autism
www.mghcme.org
Who should have a microarray?
• Everyone with developmental delay
without a clear genetic diagnosis
• Low IQ and dysmorphic features are not
clinically predicitive
www.mghcme.org
Case Study 4
• JT is a 7yr-old boy with a being followed up after a
recent diagnosis of ASD
• Born spontaneously at 36/40; no NICU required
• Presented at 5yrs due to concerns about social
interaction raised by kindergarten
• Coping well at school, above average performance in
some subjects
• Father is an engineer who has few social interests and
collects bottle caps
• Mother has good social interaction
• Microarray shows 200kb duplication at 19q13.41
www.mghcme.org
Case Study 4
• 19q13.41 duplication contains two genes: – MYADM - myeloid-associated differentiation marker
– NLRP12 - NLR family, pyrin domain containing 12 • “Mutations cause familial cold autoinflammatory syndrome
type 2”
• Rare (no other reported cases)
• Inherited from the mother
• Variant of unknown significance (VOUS)
• Hard to act on clinically
• But, always check the latest research
www.mghcme.org
Complex Genetics
• No clear segregation patterns in families
• Genetic heterogeneity
• Allelic heterogeneity
• GxG, GxE
• Low penetrance, variable expressivity
• Common polymorphism and rare variant
www.mghcme.org
Whole exome/genome sequencing
• Use of next-gen sequencing genome-wide – 3-4 x 10-6 per genome
• ‘Exome’ approaches target only coding – 10,000 per exome
• Challenge = analysis! [and $$$$]
• Other findings (~2% actionable)
– 100 LoF, 20 ko, 75 ‘pathogenic’, 50 unique
• Current estimated yield – Autism ~10%
• Recessive, X-linked, de novo
www.mghcme.org
Data from two studies leads to 50 genes (FDR <10%)
FOXP1 GIGYF1 KMT2E
MED13L DIP2A WAC
TCF7L2 KDM5B
CHD2 WDFY3 TNRC6B KDM6B DSCAM
PHF2 RIMS1
NCKAP1 ANKRD11
CTTNBP2 BCL11A
TRIO MLL3
APH1A ASXL3 MIB1 VIL1 RELN
CDC42BPB MYT1L CUL3
NR3C2 ASH1L ETFB
SYNGAP1 CACNA2D3
GABRB3 SETD5
SUV420H1 NAA15 PTEN
MYO9B
POGZ ADNP CHD8 TBR1
KATNAL2 GRIN2B ANK2 SCN2A ARID1B DYRK1A
(23) (17)
(10)
Iossifov et al, Nature, 2014 De Rubeis et al, Nature, 2014
www.mghcme.org
Case Study 5
• NP is an 8yr-old boy diagnosed with ASD, intellectual
disability and attention problems
• Unremarkable birth history
• Head circumference on 90th centile; height on 75th;
weight on 50th
• Subtle dysmorphic features
• Severe sleep disruption – often goes 72hrs without sleep
• One afebrile seizure, but not on medication
• Recurrent constipation
www.mghcme.org
Case Study 5
• Exome sequencing reveals de novo CHD8 nonsense
mutation
• Important characteristics:
– ‘Typical’ ASD presentation
– Sleep/GI problems (but not reliably)
– Large head (but not reliably)
• Exome sequencing picks up many single gene
disorders
– ~10% diagnostic yield
– Not routine practice yet...
www.mghcme.org
Your Next Case in Psychiatry
www.mghcme.org
Take Home Message
• Autism is predominantly a genetic disorder
• Accurate diagnoses of ASD, family history, physical examination are essential
• Every child with autism should have: – MECP2/FMR1/PKU testing
– Microarray
– Referral to clinical geneticist if syndromic features
• Genetic diagnosis should be revisited every 2-3 years
• Exome sequencing likely to be routine soon
www.mghcme.org
Molecular Genetic Examination of Autism
www.mghcme.org
Role of Molecular Genetic Assessment
for Autism in Clinical Setting
Young Shin Kim, MD, MS, MPH, PhD Director
STAR Center for ASD and NDDs Psychiatric Genetic Epidemiology
Associate Professor Dept. of Psychiatry, UCSF